| CORBUS PHARMACEUTICALS |
| USA |
| Gesundheit |
| US21833P3010 / A3D54P |
| 3371 (Frankfurt) / CRBP (NASDAQ) |
| FRA:3371, ETR:3371, 3371:GR, NASDAQ:CRBP |
| - |
| https://www.corbuspharma... |
|
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for oncology and obesity. The company advances a pipeline of targeted treatments, including CRB-701, a next-generation an..
>Volltext.. |
| 181.24 Mio. EUR |
| 62.18 Mio. EUR |
| - |
| -77.17 Mio. EUR |
| -72.85 Mio. EUR |
| -5.01 EUR |
| 1.04 Mio. EUR |
| 22.45 Mio. EUR |
| - |
| 7.64 |
| - |
| -57.39% |
| - |
| - |
| - |
| - |
| CORBUS PHARMACEUTICALS, CORBUS PHARMA, CORBUS PHARMACEUTICAL |
| 26.05.26 |